David W. Taylor

2016- Molecular Biosciences University of Texas at Austin, Austin, Texas, U.S.A. 
"David Taylor"
Mean distance: (not calculated yet)


Sign in to add mentor
Hong-Wei Wang grad student 2013 Yale (Physics Tree)
 (Structural Basis for RNA Processing by Human Dicer.)
Jennifer A. Doudna post-doc 2014-2016 UC Berkeley
Eva Nogales post-doc 2014-2016 UC Berkeley
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Taylor D, Schwartz E, Bravo J, et al. (2023) Type III CRISPR-Cas effectors act as protein-assisted ribozymes during RNA cleavage. Research Square
O'Brien RE, Bravo JPK, Ramos D, et al. (2023) Structural snapshots of R-loop formation by a type I-C CRISPR Cascade. Molecular Cell
Bravo JPK, Hallmark T, Naegle B, et al. (2023) RNA targeting unleashes indiscriminate nuclease activity of CRISPR-Cas12a2. Nature. 613: 582-587
Yelland JN, Bravo JPK, Black JJ, et al. (2022) A single 2'-O-methylation of ribosomal RNA gates assembly of a functional ribosome. Nature Structural & Molecular Biology
Bravo JPK, Aparicio-Maldonado C, Nobrega FL, et al. (2022) Structural basis for broad anti-phage immunity by DISARM. Nature Communications. 13: 2987
Schwartz EA, McBride TM, Bravo JPK, et al. (2022) Structural rearrangements allow nucleic acid discrimination by type I-D Cascade. Nature Communications. 13: 2829
Bravo JPK, Liu MS, Hibshman GN, et al. (2022) Structural basis for mismatch surveillance by CRISPR-Cas9. Nature
Steens JA, Zhu Y, Taylor DW, et al. (2021) SCOPE enables type III CRISPR-Cas diagnostics using flexible targeting and stringent CARF ribonuclease activation. Nature Communications. 12: 5033
Zhou Y, Bravo JPK, Taylor HN, et al. (2021) Structure of a type IV CRISPR-Cas ribonucleoprotein complex. Iscience. 24: 102201
Bravo JPK, Dangerfield TL, Taylor DW, et al. (2021) Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication. Molecular Cell
See more...